Shandong Kexing Bioproducts Co,.Ltd (688136.SS)
CNY 20.64
(5.84%)
CNY 20.64
(5.84%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 888.72 Million CNY | -10.13% |
| 2022 | 991.71 Million CNY | -2.83% |
| 2021 | 1.02 Billion CNY | 4.56% |
| 2020 | 976.02 Million CNY | 0.54% |
| 2019 | 970.81 Million CNY | 34.39% |
| 2018 | 722.37 Million CNY | 48.42% |
| 2017 | 486.71 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 182.88 Million CNY | -30.26% |
| 2024 Q1 | 261.98 Million CNY | 32.09% |
| 2024 Q2 | 262.22 Million CNY | 0.09% |
| 2023 Q2 | 232.07 Million CNY | -0.98% |
| 2023 FY | 891.28 Million CNY | -10.13% |
| 2023 Q3 | 226.49 Million CNY | -2.4% |
| 2023 Q1 | 234.37 Million CNY | -16.63% |
| 2023 Q4 | 198.33 Million CNY | -12.43% |
| 2022 Q3 | 228.48 Million CNY | -16.55% |
| 2022 Q2 | 273.81 Million CNY | 31.46% |
| 2022 Q1 | 208.29 Million CNY | -31.58% |
| 2022 FY | 991.71 Million CNY | -2.83% |
| 2022 Q4 | 281.11 Million CNY | 23.03% |
| 2021 FY | 1.02 Billion CNY | 4.56% |
| 2021 Q3 | 240.98 Million CNY | -2.99% |
| 2021 Q4 | 304.43 Million CNY | 26.33% |
| 2021 Q1 | 226.72 Million CNY | -9.4% |
| 2021 Q2 | 248.41 Million CNY | 9.57% |
| 2020 Q3 | 257.65 Million CNY | 44.03% |
| 2020 FY | 976.02 Million CNY | 0.54% |
| 2020 Q4 | 250.23 Million CNY | -2.88% |
| 2020 Q2 | 178.89 Million CNY | -38.35% |
| 2020 Q1 | 290.16 Million CNY | 7.15% |
| 2019 Q3 | 157.65 Million CNY | 0.0% |
| 2019 FY | 970.81 Million CNY | 34.39% |
| 2019 Q4 | 270.78 Million CNY | 71.76% |
| 2018 FY | 722.37 Million CNY | 48.42% |
| 2017 FY | 486.71 Million CNY | 0.0% |